Skip to main content

Inventory variation notice: revoked CBI and updates to terms of listing on specific information requirements - 1 April 2026

The AICIS Executive Director varied the terms of the Inventory listing under section 94 of the Industrial Chemicals Act 2019 for the following chemical because approval had been revoked for the proper name of the industrial chemical to be treated as confidential business information (CBI).

The Executive Director has also subsequently varied the terms of Inventory listing under section 85 of the Industrial Chemicals Act 2019 to provide more details on specific information requirements (SIR) for the chemical shown in this list.

CAS Number2097886-94-5
Chemical Name2-Propenoic acid, 2-methyl-, C12-15-branched and linear alkyl esters, polymers with 2-(dimethylamino)ethyl methacrylate and Me methacrylate, tert-Bu 2-ethylhexaneperoxoate-initiated
Molecular FormulaUnspecified
Specific information requirementsObligations to provide information apply.
Listing date30 March 2026
Specific information requirements as varied

Obligations to provide information apply. These obligations are:

  1. If the assessment report about the chemical recommends secondary notification of the chemical in particular circumstances and any of the circumstances occur in relation to the introduction (importation or manufacture) of the chemical by a person, then the person introducing this chemical must tell us in writing within 28 calendar days that the circumstances have occurred.
  2. A person who introduces this chemical must tell us in writing within 28 calendar days if they become aware of any of the following circumstances, namely, that since the assessment under the Industrial Chemicals (Notification and Assessment) Act 1989:
    1. the function or use of the chemical has changed, or is likely to change, significantly;
    2. the amount of the chemical being introduced has increased, or is likely to increase, significantly;
    3. in the case of a chemical not manufactured, or proposed to be manufactured, in Australia at the time of the assessment — it has begun to be manufactured in Australia;
    4. the method of manufacture of the chemical in Australia has changed, or is likely to change, in a way that may result in an increased risk of an adverse effect of the chemical on occupational health and safety, public health or the environment;
    5. additional information has become available to the person as to an adverse effect of the chemical on occupational health and safety, public health or the environment.
       
Variation date 31 March 2026
Published date
Was this page helpful?
For broken links or technical issues, please provide as much detail as possible. Do not include your name, email address and other personal or commercially sensitive information.

Sign up to our monthly newsletter